Lifecore Biomedical
LFCR
LFCR
81 hedge funds and large institutions have $121M invested in Lifecore Biomedical in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $149M → $121M (-$27.9M)
39% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 28
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
81
Holding in Top 10
3
Calls
$124K
Puts
$106K
Top Buyers
| 1 | +$39M | |
| 2 | +$1.79M | |
| 3 | +$1.74M | |
| 4 |
Morgan Stanley
New York
|
+$866K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$735K |
Top Sellers
| 1 | -$6.49M | |
| 2 | -$5.03M | |
| 3 | -$2.7M | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$2.65M |
| 5 |
ICM
ISZO Capital Management
New York
|
-$2.42M |